Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 982 | 6736-03-4 |
| Dose | Unit | Route |
|---|---|---|
| 0.20 | ml | None |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,IGF1R,IKBKB,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK9,MAPKAPK2,MET,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CD,PIK3CG,PIM2,PLK1,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 | 60 | |||
| kinase-selectivity-class | AXL,BRAF,CDK4,CDK9,DDR1,EPHB4,ERBB2,GRK2,IRAK3,MAP2K6,MAP3K7,MAPK10,MAPK7,MTOR,STK33,SYK,TEK,ZAP70 | 18 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| June 27, 1960 | FDA | WYETH PHARMS INC |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | S01EB03 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIGLAUCOMA PREPARATIONS AND MIOTICS Parasympathomimetics |
| FDA CS | M0011640 | Iodine |
| FDA MoA | N0000000177 | Cholinesterase Inhibitors |
| MeSH PA | D002800 | Cholinesterase Inhibitors |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D008916 | Miotics |
| MeSH PA | D010277 | Parasympathomimetics |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018678 | Cholinergic Agents |
| CHEBI has role | CHEBI:37733 | EC 3.1.1.8 (cholinesterase) inhibitor |
| CHEBI has role | CHEBI:39456 | antiglaucoma drug |
| CHEBI has role | CHEBI:51068 | miotic |
| FDA EPC | N0000175723 | Cholinesterase Inhibitor |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Esotropia | indication | 16596007 | DOID:9840 |
| Glaucoma | indication | 23986001 | DOID:1686 |
| Stargardt's disease | indication | 70099003 | |
| Open-angle glaucoma | indication | 84494001 | DOID:1067 |
| Irritable bowel syndrome | contraindication | 10743008 | DOID:9778 |
| Peptic ulcer | contraindication | 13200003 | DOID:750 |
| Increased gastric tonus | contraindication | 18644006 | |
| Muscle weakness | contraindication | 26544005 | |
| Parkinsonism | contraindication | 32798002 | |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Retinal detachment | contraindication | 42059000 | DOID:5327 |
| Low blood pressure | contraindication | 45007003 | |
| Bradycardia | contraindication | 48867003 | |
| Diarrhea | contraindication | 62315008 | |
| Iritis | contraindication | 65074000 | DOID:1406 |
| Disturbance of salivary secretion | contraindication | 78948009 | |
| Decreased respiratory function | contraindication | 80954004 | |
| Epilepsy | contraindication | 84757009 | DOID:1826 |
| Uveitis | contraindication | 128473001 | DOID:13141 |
| Urinary incontinence | contraindication | 165232002 | |
| Asthma | contraindication | 195967001 | DOID:2841 |
| Pregnancy, function | contraindication | 289908002 | |
| Hyperhidrosis | contraindication | 312230002 | |
| Angle-closure glaucoma | contraindication | 392291006 | DOID:13550 |
| Myocardial infarction in recovery phase | contraindication | 418044006 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Acetylcholinesterase | Enzyme | INHIBITOR | CHEMBL | CHEMBL |
| ID | Source |
|---|---|
| 513-10-0 | SECONDARY_CAS_RN |
| 4018498 | VANDF |
| C0301366 | UMLSCUI |
| CHEBI:4753 | CHEBI |
| CHEMBL1201341 | ChEMBL_ID |
| DB01057 | DRUGBANK_ID |
| CHEMBL1200367 | ChEMBL_ID |
| 10548 | PUBCHEM_CID |
| 9074 | IUPHAR_LIGAND_ID |
| C061212 | MESH_SUPPLEMENTAL_RECORD_UI |
| 0F350BVT6S | UNII |
| 3740 | RXNORM |
| 4649 | MMSL |
| 001711 | NDDF |
| 004689 | NDDF |
| 387073002 | SNOMEDCT_US |
| 387339003 | SNOMEDCT_US |
| 60682004 | SNOMEDCT_US |
| D004456 | MESH_DESCRIPTOR_UI |
| 662 | INN_ID |
None